EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication

Xiaoyan Ma, Jiali Lv, Shuai Zhang, Xiaofeng Zhang, Xia Lin, Shengxu Li iD, Lin Yang iD, Fuzhong Xue, Fan Yi, Tao Zhang iD

Nutrients · 2024

DOI: 10.3390/nu16142355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Xiaoyan Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Antihypertensive Agents, Hypertension, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science Fund for Creative Research Groups of the National Natural Science Foundation of China, Shandong University Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to examine the effects of habitual iron supplementation on the risk of CKD in individuals with different hypertensive statuses and antihypertension treatment statuses. We included a total of 427,939 participants in the UK Biobank study, who were free of CKD and with complete data on blood pressure at baseline. Cox proportional hazards regression models were used to examine the adjusted hazard ratios of habitual iron supplementation for CKD risk. After multivariable adjustment, habitual iron supplementation was found to be associated with a significantly higher risk of incident CKD in hypertensive participants (HR 1.12, 95% CI 1.02 to 1.22), particularly in those using antihypertensive medication (HR 1.21, 95% CI 1.08 to 1.35). In contrast, there was no significant association either in normotensive participants (HR 1.06, 95% CI 0.94 to 1.20) or in hypertensive participants without antihypertensive medication (HR 1.02, 95% CI 0.90 to 1.17). Consistently, significant multiplicative and additive interactions were observed between habitual iron supplementation and antihypertensive medication on the risk of incident CKD (p all interaction < 0.05). In conclusion, habitual iron supplementation was related to a higher risk of incident CKD among hypertensive patients, the association might be driven by the use of antihypertensive medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicAntihypertensive AgentsHypertensionDietary SupplementsHumansMaleFemaleMiddle AgedAgedRisk FactorsIronProportional Hazards ModelsAdultBlood PressureUnited KingdomIncidence

Stichwörter der Autor:innen

antihypertension medicationchronic kidney diseasehypertensioniron supplementation

Substanzen

Antihypertensive AgentsIron

Autor:innen und Institutionen

  • Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Children's Minnesota Research Institute, Children's Minnesota, Minneapolis, MN 55404, USA.
  • Department of Cancer Epidemiology and Prevention Research, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, AB T2V 0N5, Canada.
  • Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 0N5, Canada.
  • The Key Laboratory of Infection and Immunity of Shandong Province, Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China.

ORCID-Profile: Shengxu Li, Lin Yang, Tao Zhang

Förderung

  • National Natural Science Foundation of China
  • Science Fund for Creative Research Groups of the National Natural Science Foundation of China
  • Shandong University Distinguished Young Scholars

Zitieren

APA

Ma, X., Lv, J., Zhang, S., Zhang, X., Lin, X., Li, S., Yang, L., Xue, F., Yi, F., & Zhang, T. (2024). Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication. Nutrients. https://doi.org/10.3390/nu16142355

Vancouver

Ma X, Lv J, Zhang S, Zhang X, Lin X, Li S, et al. Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication. Nutrients. 2024. doi:10.3390/nu16142355

BibTeX
@article{Ma2024,
  author = {Ma, Xiaoyan and Lv, Jiali and Zhang, Shuai and Zhang, Xiaofeng and Lin, Xia and Li, Shengxu and Yang, Lin and Xue, Fuzhong and Yi, Fan and Zhang, Tao},
  title = {Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16142355}
}
Kostenlos starten →